Accordingly, we found a positive correlation between FOXA1 and AR expression in breast tumors (Fig. 7G, Supplementary Fig. 5H), while transient silencing of FOXA1 led to decreased AR mRNA expression levels in SNAI1-KO cells (Fig. 7H). The gene discussed is FOXA1; the disease is breast neoplasm.